EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Research Update/Research Update IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05
IGEA Pharma N.V. / Key word(s): Research Update/Research Update25-Nov-2021 / 23:10 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05.